Category: North America

March 15, 2021 Off

Roche buys genMak for $1.8 billion

By Dino Mustafić

Roche is buying GenMark at a price of US$ 24.05 per share in an all-cash transaction, the companies announced Monday agreement with a total transaction value of approximately US$ 1.8 billion.

January 28, 2021 Off

Moderna confirms talking with the US on 100M doses of Cov-19 vaccine

By Dino Mustafić

After the US president’s Biden said the US Federal government would buy 100 million doses of the COVID-19 vaccine from Moderna and another 100 million from Pfizer, Moderna today confirmed that it is in discussion with the U.S. government to purchase an additional 100 million doses of the Moderna COVID-19 Vaccine for delivery in the third quarter of 2021.

January 27, 2021 Off

Teneobio cleared for it’s treatment of mCRPC in USA

By Dino Mustafić

Teneobio, Inc. and its affiliate TeneoThree, Inc. announced today that their investigational new drug application (IND) for TNB-585, a bispecific T-cell engaging antibody for the treatment of metastatic castrate resistant prostate cancer (mCRPC) was cleared for the initiation of Phase I clinical studies by the US Food and Drug Administration (FDA) on January 23, 2021.

December 19, 2020 Off

Moderna’s COVID-19 vaccine authorized in U.S.

By BusinessWire

U.S. FDA has authorized mRNA vaccine against COVID-19 for emergency use as total of 200 million doses ordered by the U.S government to date, with an option to purchase up to an additional 300 million doses, while approximately 20 million doses will be delivered by the end of December 2020.

December 17, 2020 Off

Merck’s supplemental BLA in priority review for Keytruda chemotherapy combo

By BusinessWire

The FDA has accepted and granted priority review for a new supplemental Biologics License Application (sBLA) for KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with platinum and fluoropyrimidine based chemotherapy for the first-line treatment of patients with locally advanced unresectable or metastatic carcinoma of the esophagus and gastroesophageal junction

December 15, 2020 Off

Moderna to supply Singapore with COVID-19 vaccine

By Dino Mustafić

Moderna has made a deal with the Ministry of Health of Singapore to supply mRNA-1273, Moderna’s vaccine candidate against COVID-19, to support ongoing efforts to secure access to a safe and effective COVID-19 vaccine for the people of Singapore.